XOMA (XOMA)
(Delayed Data from NSDQ)
$25.41 USD
+0.05 (0.20%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $25.68 +0.27 (1.06%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Income Statements
Fiscal Year end for XOMA Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 5 | 6 | 38 | 29 | 18 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 5 | 6 | 38 | 29 | 18 |
Selling & Adminstrative & Depr. & Amort Expenses | 47 | 23 | 21 | 17 | 22 |
Income After Depreciation & Amortization | -42 | -17 | 18 | 12 | -4 |
Non-Operating Income | 2 | 0 | -1 | 1 | 4 |
Interest Expense | 1 | 0 | 0 | 2 | 2 |
Pretax Income | -41 | -17 | 16 | 12 | -2 |
Income Taxes | 0 | 0 | 0 | -2 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -41 | -17 | 16 | 13 | -2 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -41 | -17 | 16 | 13 | -2 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -41 | -17 | 18 | 13 | -3 |
Depreciation & Amortization (Cash Flow) | 1 | 0 | 0 | 1 | 1 |
Income After Depreciation & Amortization | -42 | -17 | 18 | 12 | -4 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 11.47 | 11.41 | 12.19 | 11.50 | 8.76 |
Diluted EPS Before Non-Recurring Items | -2.66 | -1.98 | 0.65 | 0.78 | -0.23 |
Diluted Net EPS (GAAP) | -4.04 | -1.98 | 0.65 | 0.78 | -0.23 |
Fiscal Year end for XOMA Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 1.83 | 0.83 | 1.66 | 0.44 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 1.83 | 0.83 | 1.66 | 0.44 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 21.77 | 6.62 | 7.61 | 10.61 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -19.94 | -5.79 | -5.95 | -10.17 |
Non-Operating Income | NA | 0.39 | 0.28 | 0.56 | 0.36 |
Interest Expense | NA | 0.57 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -20.11 | -5.51 | -5.40 | -9.81 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -20.11 | -5.51 | -5.40 | -9.81 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -20.11 | -5.51 | -5.40 | -9.81 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 11.48 | 11.47 | 11.47 | 11.46 |
Diluted EPS Before Non-Recurring Items | NA | -0.49 | -0.60 | -0.59 | -0.98 |
Diluted Net EPS (GAAP) | NA | -1.87 | -0.60 | -0.59 | -0.98 |